Immediate Impact
21 hit
Citing Papers
Non-small-cell lung cancer
2024 Hit
Non-Small-Cell Lung Cancer in 2022: A Review for General Practitioners in Oncology
2022 Hit
Works of Javier Valencia being referenced
P-706 Randomized phase II study of sequetial versus concurrent chemoradiotherapy (CRT) in poor risk patients with inoperable stage III non-small cell lung cancer (NSCLC): Interim analysis
2005
Author Peers
Peers are selected by citation overlap in the author's most active subfields. citations · hero ref
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Javier Valencia | 19 | 16 | 10 | 10 | 9 | 10 | 50 | |
| Agnese Verzuri | 13 0.7× | 7 0.4× | 5 0.5× | 8 0.8× | 4 0.4× | 10 | 74 | |
| Chawetsan Namwat | 24 1.3× | 9 0.6× | 13 1.3× | 22 2.2× | 2 0.2× | 9 | 92 | |
| Greg Bautista | 31 1.6× | 24 1.5× | 7 0.7× | 20 2.0× | 5 0.6× | 7 | 70 | |
| Sarah Borwein | 27 1.4× | 9 0.6× | 3 0.3× | 9 0.9× | 4 0.4× | 8 | 223 | |
| Kelsey R. Landrum | 8 0.4× | 5 0.3× | 15 1.5× | 9 0.9× | 6 0.7× | 16 | 72 | |
| Reza Assadi | 4 0.2× | 15 0.9× | 4 0.4× | 7 0.7× | 4 0.4× | 13 | 86 | |
| Yaw Bediako | 62 3.3× | 21 1.3× | 20 2.0× | 39 3.9× | 2 0.2× | 16 | 219 | |
| Olu Akinyanju | 14 0.7× | 6 0.4× | 3 0.3× | 11 1.1× | 4 0.4× | 7 | 279 | |
| Kara Jacobs Slifka | 31 1.6× | 2 0.1× | 12 1.2× | 7 0.7× | 3 0.3× | 14 | 75 | |
| Ihor Kuzin | 6 0.3× | 8 0.5× | 7 0.7× | 13 1.3× | 2 0.2× | 7 | 48 |
All Works
Loading papers...